Phase II trial of first-line capecitabine plus cisplatin in patients with advanced/metastatic nasopharyngeal cancer (NPC)

被引：1

作者：

Chua, D.

Ng, W.

Yiu, H.

Seetalarom, K.

Kurnianda, J.

Sze, W.

Krishnan, G.

Shotelersuk, K.

Hong, R.

Forster, G.

机构：

[1] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China

[2] Pamela Youde Nethersole Eastern Hosp, Hong Kong, Hong Kong, Peoples R China

[3] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China

[4] Pramongkutklao Hosp, Bangkok, Thailand

[5] Sardjito Hosp, Yogyakarta, Indonesia

[6] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China

[7] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia

[8] King Chulalongkorn Mem Hosp, Bangkok, Thailand

[9] Natl Taiwan Univ Hosp, Taipei, Taiwan

[10] Hoffmann La Roche, Taipei, Taiwan

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.6033

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6033

引用

页数：1